Answers are grounded in this paper and cite their sources.
Methane hydroxylation at the dinuclear copper site of particulate methane monooxygenase (pMMO) is studied by using density functional theory calculations. The electronic, structural, and reactivity properties of a possible dinuclear copper species (μ-oxo)(μ-hydroxo)Cu(II)Cu(III) are discussed with respect to the C-H bond activation of methane. We propose that the tyrosine residue in the second coordination sphere of the dicopper site donates an H atom to the μ-η(2):η(2)-peroxoCu(II)Cu(II) species and the resultant (μ-oxo)(μ-hydroxo)Cu(II)Cu(III) species can hydroxylate methane. This species for methane hydroxylation is more favorable in reactivity than the bis(μ-oxo)Cu(III)Cu(III) species. The H-atom transfer or proton-coupled electron transfer from the tyrosine residue can reasonably induce the O-O bond dissociation of the μ-η(2):η(2)-peroxoCu(II)Cu(II) species to form the reactive (μ-oxo)(μ-hydroxo)Cu(II)Cu(III) species, which is expected to be an active species for the conversion of methane to methanol at the dicopper site of pMMO. The rate-determining step for the methane hydroxylation is the C-H cleavage, which is in good agreement with experimental KIE values reported so far.
No takes yet. Share an insight, caveat, or question.
Shiota et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: